Literature DB >> 18499993

Correlation study of benign cytomorphology and final clinical diagnosis.

Jing Zhai1, J William Harbour, Morton E Smith, Rosa M Dávila.   

Abstract

OBJECTIVE: To assess significance of cytologically benign vitreous samples and identify cellular patterns that may correspond to specific clinical entities. STUDY
DESIGN: Vitreous fluids with "negative for malignancy" cytologic diagnosis were identified from pathology department records, cytologic slides reviewed and clinical and follow-up information obtained.
RESULTS: Fifty-four cytologically benign samples were identified (1994-2004). The main indication for vitrectomy was confirmation of intraocular inflammatory process. Malignant process was included in the differential diagnoses of most samples. Macrophages or lymphocytes were the predominant cell types in 76% of cases. Most cases with macrophage or lymphocyte predominance were diagnosed as chronic uveitis or vitritis of unknown etiology. Infectious agents were identified in 7 cases with macrophage or lymphocyte predominance, 2 with abundant neutrophils and 1 with eosinophils. One had a diagnosis of malignant lymphoma, based on vitreous fluid from the opposite eye at another hospital. Three cases had blood only and 1 had lens fragments, both consistent with the diagnosis.
CONCLUSION: Most cytologic features of benign vitreous fluids did not correspond to specific clinical entities. Abundant eosinophils suggested parasitic infection; the almost exclusive presence of blood indicated hemorrhage. Based on our study, negative predictive value of a benign vitreous sample is 98%.

Entities:  

Mesh:

Year:  2008        PMID: 18499993     DOI: 10.1159/000325479

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  1 in total

1.  Cytologic features in vitreous preparations of patients with suspicion of intraocular lymphoma.

Authors:  Erika F Rodriguez; Yasir J Sepah; Hyun Soo Jang; Mohamed Ibrahim; Quan Dong Nguyen; Fausto J Rodriguez
Journal:  Diagn Cytopathol       Date:  2013-10-25       Impact factor: 1.582

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.